Bleakley Financial Group, LLC Ionis Pharmaceuticals Inc Transaction History
Bleakley Financial Group, LLC
- $3.28 Trillion
- Q3 2024
A detailed history of Bleakley Financial Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 16,678 shares of IONS stock, worth $567,218. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,678
Previous 16,340
2.07%
Holding current value
$567,218
Previous $779 Million
14.21%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$482 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$297 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$268 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...